BioSpace News Archive

Drug Development

Adverum Biotechnologies Reports Positive Interim Data from Cohorts 1-3 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced new interim clinical data from Cohorts 1-3 of the OPTIC Phase 1 dose-ranging clinical trial of ADVM-022 intravitreal (IVT) injection gene therapy in patients requiring frequent anti-VEGF injections for their wet age-related macular degeneration (AMD) and provided a business update.

May 4, 2020
·
11 min read
Business

KORU Medical Systems Announces 2020 First Quarter Financial Results

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the first quarter ended March 31, 2020 (“Q1 2020”).

May 4, 2020
·
13 min read
Business

Veeva to Release Fiscal 2021 First Quarter Results on May 28, 2020

Veeva Systems (NYSE:VEEV) will announce financial results for its first quarter which ended April 30, 2020 after market close on May 28, 2020.

May 4, 2020
·
1 min read